SCHEMBL17633720

SCHEMBL17633720

CCOC(=O)c1c(O)c2cc(Br)cc3c2n(c1=O)CCC3

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.60
KMT2A Q03164 4/20 0.56
MAPK1 P28482 4/20 0.56
MEN1 O00255 3/20 0.56
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
RXFP1 Q9HBX9 1/20 0.46
USP2 O75604 2/20 0.45
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
GAA P10253 2/20 0.45
ALOX12 P18054 1/20 0.45
HTT P42858 1/20 0.45
TSHR P16473 2/20 0.44
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17634257 0.83 KMT2A (0.48) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL10680989 0.82 KDM4E (0.87) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL17634137 0.80 KDM4E (0.51) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL9274664 0.78 KDM4E (0.66) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL17633746 0.78 KDM4E (0.60) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL17642710 0.78 ALDH1A1 (0.56) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL19205717 0.78 KMT2A (0.51) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL10677803 0.75 KDM4E (1.00) KDM4EKMT2AMAPK1MEN1ALDH1A1
SCHEMBL17633654 0.73 EGLN1 (0.55) KDM4EALDH1A1SMN1; SMN2USP2
SCHEMBL3811645 0.72 LMNA (0.49) KDM4EKMT2AMAPK1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197900-B1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME (US) 2020-02-12 EP disclosed
US-9969752-B2 Inhibitors of HIF prolyl hydroxylase MERCK SHARP & DOHME CORP. (US) 2018-05-15 US disclosed
US-20170233412-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2017-08-17 US disclosed
EP-3197900-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE Merck Sharp & Dohme Corp. (US) 2017-08-02 EP disclosed
WO-2016045127-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2016-03-31 WO disclosed
WO-2016049099-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233412-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE HIF1AN, HIF1A, EGLN2 KDM4E 430/4885KMT2A 940/4885MAPK1 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.